Stay updated on platform news and potential beta tests.

Regular

Results in at least half of all pubished life science studies cannot be reproduced when researchers try to verify results. Head of Pre-Clinical Pharmacology at Deerfield Discovery & Development, LLC (3DC) Christine Brideau, PhD, describes recent reproducibility studies from Bayer and Amgen—and offers suggestions for narrowing the verification gap.

Images from Cure Tuesday Talks - The Research Reproducibility Problem and its Impact on Drug Discovery

Cure Tuesday Talks banner image Christine Brideau

This exciting initiative is set to make a significant impact on the startup ecosystem, offering valuable opportunities for growth and innovation. 

The Xchange prize for startups is up and running!

Tuesday Talks: The Research Reproducibility Problem and its Impact on Drug Discovery

Seema Kumar 

Vice President, Preclinical Pharmacology, Deerfield Discovery and Development (3DC)

The Research Reproducibility Problem and Its Impact on Drug Discovery